Alzheimer’s disease (AD) is a widespread neurodegenerative disorder that currently lacks early and accessible diagnostic tools. While the electroretinogram (ERG) provides a non-invasive way to detect retinal dysfunction linked to neurodegeneration, it has been unclear whether reliable biomarkers can be derived beyond traditional amplitude and latency measurements. Here, we implemented a multi-domain signal processing framework to analyze ERG signals from 46 participants (20 with AD and 26 controls) using a portable, handheld device (RETeval). The framework consists of five complementary techniques: multiscale fuzzy entropy, FFT harmonic analysis, stimulus-response wavelet time-frequency coherence, a novel inter-cycle lag variant of sample entropy, and discrete wavelet transform. We identified seven significant candidate biomarkers, five of which showed large effect sizes. A logistic regression classifier combining three of these biomarkers achieved an ROC-AUC of 0.858, with 70.0% sensitivity and 88.5% specificity. These findings suggest that multi-domain ERG analysis captures retinal temporal dysfunction signatures in AD patients that are not accessible via standard clinical analysis, supporting the use of portable ERG devices as a promising, non-invasive tool for early AD detection.